아밀로이드 베타 단백질에 의해 유도된 신경세포 독성에 대한 황정의 억제 효과 탐색 = Protective Effects of Polygonatum odoratum Extracts on Amyloid β-protein-induced Death in Neuronal Cells

다국어 초록 (Multilingual Abstract)

The amyloid β-protein (Aβ) is the principal component of the senile plaques characteristic of Alzheimer’s disease (AD) and elicits a toxic effect on neurons in vitro and in vivo. Many environmental factors including antioxidants and proteoglycans modify Aβ toxicity. In this study, we have investigated the protective effects of organic solvent-extracts of Polygonatum odoratum fractions pre-extracted with methanol on Aβ-induced oxidative cell death in cultured rat pheochromocytoma (PC12) cells. For this study, we used MTT reduction assay for detection of protective effects of organic solvent-extracts of Polygonatum odoratum fractions pre-extracted with methanol on Aβ25-35-induced cytotoxicity to PC12 cells. We also used cell-based β-secretase assay system to investigate the inhibitory effect of organic solvent-extracts of Polygonatum odoratum on β-secretase activity. We previously reported that methanol extracts of Polygonatum odoratum strongly attenuated cytotoxicity induced by the three A fragments (Aβ25-35, Aβ1-42 Aβ1-43) to both SK-N-MC and PC12 cells. In the present study, we found that the organic solvent extracts of Polygonatum odoratum fractions pre-extracted with methanol had the strong protective effects against Aβ25-35-induced cytotoxicity to PC12 cells and inhibitory potency to β-secretase activity. These results suggest that organic solvent extracts of Polygonatum odoratum fractions pre-extracted with methanol may contain the protective component(s) against Aβ-induced cell death in PC12 cells as well as inhibitory component(s) to β-secretase activity. (Cancer Prev Res 13, 197-204, 2008)

참고문헌 (Reference)

1 문자영, "아밀로이드 베타 단백질에 의해 유도된 신경세포 독성에 대한 백합과 숙근류의 억제 효과 탐색" 대한암예방학회 10 (10): 242-250, 2005

2 康秉秀, "本草學" 永林社 594-595, 1995

3 陶弘景, "名醫別錄" 人民衛生出版社 23-, 1986

4 Selkoe, D.J., "Translating cell biology into therapeutic advances in Alzheimer's disease" 399 (399): A23-A31, 1999

5 Andrea Zangara, "The psychopharmacology of huperzine A: an alkaloid with cognitive enhancing and neuroprotective properties of interest in the treatment of Alzheimer’s disease" 75 : 675-686, 2003

6 Bastinetto, S., "The ginkgo biloba extract (EGb 761) protects hippocampal neurons against cell death induced by β- amyloid" 12 : 1882-1890, 2000

7 Henderson, V.W., "The epidemiology of estrogen replacement therapy and Alzheimer's disease" 48 (48): S27-S35, 1997

8 Oken, B.S., "The efficacy of Ginkgo biloba on cognitive function in Alzheimer disease" 55 : 1409-1415, 1998

9 Badia, A., "Synthesis and evaluation of tarcrine-huperzine A hybrids as acetylcholinesterase inhibitors of potential interest for the treatment of Alzheimer’s disease" 6 : 427-440, 1998

10 Kihara, T., "Stimulation of alpha4beta2 nicotinic acetylcholine receptors inhibits beta-amyloid toxicity" 792 : 331-334, 1998

11 Skolnick, A.A., "Old Chinese herbal medicine used for fever yields possible new Alzheimer disease therapy" 277 : 776-, 1997

12 Hoshi, M., "Nontoxic amyloid beta peptide 1-42 suppresses acetylcholine synthesis. Possible role in cholinergic dysfunction in Alzheimer's disease" 272 : 2038-2041, 1997

13 Mattson, M.P., "Neuroprotective signal transduction: relevance to stroke" 21 : 193-206, 1997

14 Scott, S.A., "Nerve growth factor and Alzheimer's disease" 5 : 179-211, 1994

15 Gooch, M.D., "Molecular basis of Alzheimer's disease" 53 : 1545-1557, 1996

16 Seiger, A., "Intracranial infusion of purified nerve growth factor to an Alzheimer patient: the first attempt of a possible future treatment strategy" 57 : 255-261, 1993

17 Park, S.Y., "Discovery of natural products from Curcuma longa that protect cells from beta-amyloid insult: A drug discovery effort against Alzheimer's disease" 65 : 1227-1231, 2002

18 Pasinetti, G.M., "Cyclooxygenase-2 expression is increased in frontal cortex of Alzheimer's disease brain" 87 : 319-324, 1998

19 Harkany, T., "Cholinotoxic effects of beta-amyloid (1-42) peptide on cortical projections of the rat nucleus basalis magnocellularis" 695 : 71-75, 1995

20 Haass, C., "Cellular processing of beta-amyloid precursor protein and the genesis of amyloid beta-peptide" 75 : 1039-1042, 1993

21 Oh, M., "Cell-based assay for β-secretase activity" 323 : 7-11, 2003

22 Pike, C.J., "Beta-amyloid neurotoxicity in vitro: evidence of oxidative stress but not protection by antioxidants" 69 : 1601-1611, 1997

23 Yan, S.D., "An intracellular protein that binds amyloid- peptide and mediates neurotoxicity in Alzheimer's disease" 389 : 689-695, 1997

24 Lorenzo, A., "Amyloid fibril toxicity in Alzheimer's disease and diabetes" 777 : 89-95, 1996

25 Le Bars, P.L., "A placebo-controlled, double-blind, randomized trial of an extract of Ginko biloba for dementia, North American Egb Study Group" 278 : 1327-1332, 1997